Monitor the vote outcome at the June 9, 2026 annual meeting. Passage would enable continued equity grants, while failure could lead to increased cash compensation. The corrective nature of this filing is unlikely to move the stock.
SIGA drugs
SIGA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 11 $4.55entry
- T+1 · 6mo ago 0.00%α +0.14% · $4.55
- T+5 · 6mo ago −6.15%α −6.07% · $4.27
- T+20 · 5mo ago −3.52%α −3.21% · $4.39
- T+60 · 3mo ago −30.77%α −35.16% · $3.15
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
SIGA Technologies filed a DEFA14A supplement to its 2026 proxy statement, correcting errors in Proposal 4 regarding the amendment to the 2010 Stock Incentive Plan. The corrections remove a non-employee director compensation cap and clarify that the 1,000,000-share annual limit applies only to employees. The board continues to recommend approval of the amendment, which would increase the share pool by 6.5 million shares.
Key Financial Metrics
Key Facts
- The supplement corrects errors in the original proxy statement regarding Proposal 4 (stock plan amendment).
- Removes erroneous non-employee director compensation cap and clarifies 1,000,000-share limit applies only to employees.
- Full text of the 2010 Stock Incentive Plan is included as Annex B.
- Annual meeting scheduled for June 9, 2026; board recommends voting FOR the amendment.
- The amendment would increase authorized shares from 8.5 million to 15 million (6.5 million new shares).
Financial Impact
No immediate financial impact; the filing is a corrective supplement. If approved, the additional 6.5 million shares represent potential dilution of approximately 12.07% on a fully diluted basis (per company disclosure).
Risk Factors
- Failure to approve the amendment could force the company to use cash compensation, potentially impacting cash flow.
- Approval allows significant equity dilution (12.07% fully diluted overhang), though management claims low burn rate (1.16% 3-year average).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-020020 |
| Document: 0001140361-26-020020-index-headers.html | 0001140361-26-020020 |
| Document: 0001140361-26-020020-index.html | 0001140361-26-020020 |
| Document: 0001140361-26-020020.txt | 0001140361-26-020020 |
Track record
6 reports on SIGA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 9, 20267d ago Press Release Bearish 5/10 Entry $3.13 to $3.14 Now $2.85 +8.95% ▼ −0.32% +1.00% vs SPY
- Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $3.15 to $2.97 Now $2.85 −9.52% ▼ −5.71% −1.31% vs SPY
- Oct 28, 202619d ago Press Release Neutral 3/10 Entry $3.31 to $3.18 Now $2.85 −13.90% ▼ −3.93% −3.55% vs SPY
- May 8, 202627w ago DEFA14A Neutral 2/10 Viewing Entry $4.55 to $4.55 Now $2.85 −37.36% · 0.00% +0.14% vs SPY
- May 7, 202627w ago Press Release Bearish 6/10 Entry $4.80 to $4.55 Now $2.85 +40.63% ▲ +5.21% +5.44% vs SPY
- Mar 26, 202633w ago Press Release Neutral 4/10 Entry $4.69 to $4.65 Now $2.85 −39.21% ▼ −0.75% −0.40% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers